Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Goodwill (2016 - 2025)

Historic Goodwill for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $807.0 million.

  • Conmed's Goodwill rose 20.53% to $807.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $807.0 million, marking a year-over-year increase of 20.53%. This contributed to the annual value of $807.0 million for FY2025, which is 20.53% up from last year.
  • Per Conmed's latest filing, its Goodwill stood at $807.0 million for Q4 2025, which was up 20.53% from $806.9 million recorded in Q3 2025.
  • Conmed's Goodwill's 5-year high stood at $815.6 million during Q2 2023, with a 5-year trough of $617.5 million in Q4 2021.
  • Over the past 5 years, Conmed's median Goodwill value was $806.6 million (recorded in 2023), while the average stood at $759.0 million.
  • In the last 5 years, Conmed's Goodwill skyrocketed by 3205.73% in 2023 and then plummeted by 115.65% in 2024.
  • Conmed's Goodwill (Quarter) stood at $617.5 million in 2021, then soared by 32.05% to $815.4 million in 2022, then fell by 1.05% to $806.8 million in 2023, then dropped by 0.18% to $805.4 million in 2024, then rose by 0.21% to $807.0 million in 2025.
  • Its Goodwill was $807.0 million in Q4 2025, compared to $806.9 million in Q3 2025 and $806.9 million in Q2 2025.